Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis

[1]  Oliver Fiehn,et al.  A comprehensive urinary metabolomic approach for identifying kidney cancerr. , 2007, Analytical biochemistry.

[2]  A. Matsubara,et al.  A metabonomic approach identifies human urinary phenylacetylglutamine as a novel marker of interstitial cystitis. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  Ursula Wesselmann,et al.  AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. , 2011, The Journal of urology.

[4]  M. Litwin,et al.  Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. , 2009, Urology.

[5]  Oliver Fiehn,et al.  MINEs: open access databases of computationally predicted enzyme promiscuity products for untargeted metabolomics , 2015, Journal of Cheminformatics.

[6]  Steve Piantadosi,et al.  Multilevel regularized regression for simultaneous taxa selection and network construction with metagenomic count data , 2015, Bioinform..

[7]  Yiran Huang,et al.  MCP-1-Induced Histamine Release from Mast Cells Is Associated with Development of Interstitial Cystitis/Bladder Pain Syndrome in Rat Models , 2012, Mediators of inflammation.

[8]  Dongyu Jia,et al.  Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation. , 2015, Gynecologic oncology.

[9]  R. Dmochowski,et al.  Urodynamic studies in adults: AUA/SUFU guideline. , 2012, The Journal of urology.

[10]  David S. Wishart,et al.  Bioinformatics Applications Note Systems Biology Metatt: a Web-based Metabolomics Tool for Analyzing Time-series and Two-factor Datasets , 2022 .

[11]  Zerihun T. Dame,et al.  The Human Urine Metabolome , 2013, PloS one.

[12]  Stefan Grimme,et al.  Towards first principles calculation of electron impact mass spectra of molecules. , 2013, Angewandte Chemie.

[13]  K. Kreder,et al.  Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis. , 2006, Urology.

[14]  D. Grandér,et al.  Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes. , 2002, European journal of biochemistry.

[15]  O. Fiehn,et al.  FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. , 2009, Analytical chemistry.

[16]  P. Hanno.  International Consultation on IC – Rome, September 2004 / Forging an International Consensus: Progress in Painful Bladder Syndrome / Interstitial cystitis , 2005, International Urogynecology Journal.

[17]  Thomas O Jemielita,et al.  Symptom Variability and Early Symptom Regression in the MAPP Study: A Prospective Study of Urological Chronic Pelvic Pain Syndrome. , 2016, The Journal of urology.

[18]  Marc N Elliott,et al.  Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. , 2011, The Journal of urology.

[19]  J. Anger,et al.  Urinary Metabolite Profiling Combined with Computational Analysis Predicts Interstitial Cystitis-Associated Candidate Biomarkers , 2014, Journal of proteome research.

[20]  D. Wishart,et al.  Computational Prediction of Electron Ionization Mass Spectra to Assist in GC/MS Compound Identification. , 2016, Analytical chemistry.

[21]  M. Lucia,et al.  Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort , 2016, EBioMedicine.